Proposed rules regulating the sale of ingestible products containing hemp-derived cannabinoids in New York have been hailed as “pragmatic” and “rational” by brands attempting to navigate the regulatory minefield in the absence of federal regulations.
The Senate passed a continuing resolution Wednesday that provides short term funding in a move that will prevent a government shutdown. The resolution also included the House’s language to extend the hemp pilot program through September of 2021.
It was hard enough keeping everyone on the same compliance page and then along came COVID-19. During the pandemic, FDA has published dozens of guidance documents for the dietary supplement industry as well as other stakeholders.
The US Food and Drug Administration has announced a virtual public meeting to explore the potential sex (biological) and gender (psychosocial) differences in use and responses to cannabidiol (CBD) and other cannabinoids.